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Abstract
Purpose: Intraocular pressure (IOP) is the primary modifiable risk fac-
tor for glaucoma. Current devices measure IOP via the dynamic response
of the healthy cornea and give limited or inaccurate measurements when
biomechanical properties are altered. We seek to develop and test an ac-
curate needle-based, real-time IOP measurement device that is not cornea
dependent.
Methods: Our device combines a high-resolution pressure microsensor with
30- and 33-gauge Luer lock needles to provide IOP measurements via micro-
controller and USB interface to a computer. The device was calibrated in a
closed membrane chamber then tested and validated in the anterior and vit-
reous chambers (post-vitrecomy) of rabbit eyes. Readings were taken across
a presssure range of 0–100 mmHg, increased in 10 mmHg increments, and
were compared to Tonopen readings.
Results: Both the needle based sensor device and the Tonopen demon-
strate a linear relationship with changes in imposed pressure. The Tonopen
was found to consistently underestimate the IOP both in the anterior cham-
ber and vitrectomized vitreous chamber. Relative to the imposed pressure,
results from tonometry exhibit a significantly greater error than our needle-
based sensor device. With increased pressure (>30 mmHg), the error of the
Tonopen increased, while the error of our device does not. The 30-gauge
needle produces an insignificant improvement in accuracy over the 33-gauge
needle.
Conclusions: This needle-based sensor device enables accurate IOP mea-
1
surements in the anterior chamber and post-vitrectomy vitreous chamber.
Translational relevance: Direct measure of IOP in the anterior and vitre-
ous chambers provides a practical alternative for patients with altered corneal
biomechanics.
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1. Introduction1
Intraocular pressure (IOP) is the primary modifiable risk factor in the de-2
velopment and progression of glaucoma. Reliable measurements of IOP are3
crucial in the management of this sight-threatening disease. The gold stan-4
dard for IOP measurement for more than 50 years has been Goldmann ap-5
planation tonometry (GAT).1 GAT is a non-invasive measurement technique6
that infers IOP from the force required to flatten a portion of the cornea.7
However, accurate GAT assessment of IOP is dependent on an ideal eye and8
can be affected by many factors including corneal thickness, corneal curva-9
ture, and irregular corneal biomechanical properties.2 Furthermore, GAT is10
not possible in patients with a Boston keratoprosthesis (KPro) due to the11
inelasticity of the implant.12
New technologies have attempted to address the shortcomings of GAT.13
The accuracy of Dynamic Contour Tonometry is less affected by corneal14
thickness than corneal curvature.3 The Ocular Response Analyzer likewise15
is less influenced by corneal properties and provides measures of corneal16
biomechanics through corneal hysteresis.4 The Diaton tonometer measures17
IOP through transpalpebral tonometry, and can be used to measure IOP18
in KPro patients, but the device is not very accurate.5 Implantable IOP19
measurement devices circumvent potential artifacts by directly measuring20
IOP but require a surgical procedure.6,721
Intravitreal injections for the treatment of retinal disorders are performed22
millions of times per year.8 Intravitreal injections have been widely adopted23
due to their favorable safety profile, with infections associated with fewer24
than 1 in 6,000 injections.9 Anterior chamber paracentesis is less common25
but is also safe and has a low risk of iatrogenic complications.10 This presents26
the possibility of directly measuring intraocular pressure in the anterior or27
vitreous chambers. Advances in micro-manometric technology have made28
this increasingly feasible for the clinician. Here, we present a novel direct29
IOP measurement device that provides rapid and accurate measurements30
and is independent of the cornea. The device was tested ex vivo in rabbits31





A high-resolution pressure sensor (2SMPP-03, OMRON, Kyoto, Japan)36
was integrated with a custom designed circuit that enables obtaining ac-37
curate measurements of the IOP via a USB interface as shown in Figure38
1. The pressure sensor and circuit were assembled in a custom designed, 3D39
printed, and palm-sized housing. A 30- or 33-gauge needle (PRE-33013, TSK40
Laboratory, Japan) was primed with sterile balanced salt solution (BSS) and41
connected to a pressure sensor through a luer lock mechanism. Analog signal42
delivered from the pressure sensor was converted to digital via an Arduino43
Due (ADU, A000062, Arduino, Ivrea, Italy) board at an acquisition rate of44
50ms (20Hz). Internal circuitry ensures that pressures outside the measure-45
ment range do not create voltages large enough to damage the Arduino Due.46
This is achieved via a Wheatstone bridge built into the pressure sensor. The47
voltage is then amplified with a precise gain using an instrumentation ampli-48
fier (INA126, Texas Instruments, Dallas, TX, USA) that sets the sensitivity49
of the pressure measurement. The output is then limited using two limiter50
circuits; one for the upper bound and the other for the lower bound of the51
expected pressure range. The upper and lower bounds are set by the inter-52
nal ADC of the Arduino Due, but the sensitivity of the measurement can be53
changed by adjusting the feedback resistor of the instrumentation amplifier.54
The internal Arduino Due ADC then digitizes the analog signal at a user-55
defined sampling rate. The digital signal transmitted to a computer through56
a standard USB interface was used to infer the output reading in mm Hg57
based on calibration measures described below.58
Figure 1: a) Illustration of the device acquisition set-up. b) Image of the circuit
and disposable part which get assembled in a custom 3D printed housing.
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Calibration and Testing: A high-resolution microfluidics pressure con-59
trol system (microfluidics control, OB1, Elveflow®, Paris, France) was used60
to control the pressure imposed on the pressure sensor to produce a cali-61
bration curve. This was obtained in the first instance by connecting the62
microfluidics control system to the sensor needle through an elastic mem-63
brane to better represent an actual eye. This test was conducted to ensure64
the sensitivity of the micro-manometric system was sufficient to capture the65
changes imposed by the microfluidics control system and subsequently obtain66
the calibration equation for the sensor. An elastic ex vivo model of the eye67
was constructed to which the microfluidics control system was connected us-68
ing a 25-gauge (25G 1, BD Eclipse®, NJ, USA) needle. The elastic model is69
a closed membrane chamber comprised of a polymer with mechanical prop-70
erties similar to a cornea.11 The membrane chamber was filled with BSS71
and a vaccuum chamber was used to eliminate dissolved air that could later72
lead to entrapped air bubbles. The microfluidics control system added or73
removed BSS in the membrane chamber to increase or decrease the pressure74
of the system. The needle sensor device was connected to the closed cham-75
ber with either of two needle sizes (30-g × 1/2 in and 33-g × 1/2 in) and the76
pressure was varied using the microfluidics control system. Sensor readings77
were recorded while increasing the pressure from 0 to 103.4 mm Hg (2 Psi),78
and back to 0 with steps of 10.3 mm Hg (0.2 Psi). The readings were used79
to calibrate the sensor relative to the pressure imposed by the microfluidics80
control system. Standard regression analysis was used to compute the R281
values and establish a linear correlation between the sensor readings (S) and82
the imposed pressure (PIN) such that: S = aPIN + b, where a and b are83
correlation coefficients.84
The sensor needle device was then tested in ex vivo rabbit eyes. The85
microfluidics control system was connected to a 25-gauge needle and inserted86
into the anterior chamber of the eyes. The sensor needle was then inserted87
into the anterior chamber and likewise maintained in a fixed position on a88
stabilizer arm as shown in Figure 2. Two needle sizes, 30-g × 1/2 in and 33-g89
× 1/2 in, were used to obtain sensor readings for the pressure changes in the90
anterior chamber. The input pressure in the anterior chamber pressure was91
varied from 0 to 103.4 mm Hg (2 Psi) in 10 mm Hg (0.2 Psi) increments.92
The device was evaluated using the calibration equation from the elastic93
membrane chamber, PM =
S−b
a
, where PM is the measured pressure, S is94
the sensor reading, a and b are the linear correlation coefficients. The IOP95
was also measured using a Tonopen following the device reading for each96
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increment in pressure. Measurements were repeated for five eyes using both97
needle sizes (10 eyes total).98
Figure 2: a) Image of the test setup in rabbit eyes, b) illustration of supply
pressure and sensor needle. The 25 g needle was used to supply pressure from
the microfluidics control system and the sensor needle used to measure the
pressure change in the anterior chamber.
The tests were repeated in the vitreous chamber of vitrectomized rabbit99
eyes. Similar to the anterior chamber measurements, a 25 g needle attached100
to the microfluidics control system was inserted into the vitreous chamber101
and held in a fixed position using a stabilizer arm. The sensor needle was102
inserted into the vitreous chamber and two needle sizes, 30-g × 1/2 in and 33-103
g × 1/2 in, were again used to measure the pressure changes in the vitreous104
chamber. The pressure imposed by the microfluidics control system was105
varied from 0 to 103.4 mm Hg (2 Psi) in 10 mm Hg (0.2 Psi) increments and106
sensor readings taken at each increment. The IOP was also measured using107
a Tonopen simultaneously with the sensor readings.108
3. Results109
Calibration: The sensor of the micro-manometry system was tested110
through a connection to an elastic membrane chamber that exhibits a linear111
relationship with the pressure imposed by the microfluidics control system112
for both the needles, 30-g × 1/2 in and 33-g × 1/2 in. Scatter plots of the113
pressure recorded by the sensor needle device against the pressure imposed114
by the microfluidics control system are shown in Figure 3.115
6
Figure 3: Sensor needle device readings obtained by connection to the microflu-
idics control system in an elastic membrane chamber using 30-g × 1/2 in and
33-g × 1/2 in needles.
The sensor reading is linearly dependent (R2 > 0.99) over 0 to 103.4 mm116
Hg, and the change in the reading in replacing a 30-g needle with a 33-g needle117
is insignificant according to a paired T-test (p < 0.05). The results indicate118
the sensitivity of the device is sufficient to capture the changes imposed by119
the microfluidics control system over a pressure range of 0 to 103.4 mm Hg120
(2 Psi), with increments of 10.3 mm Hg (0.2 Psi). The calibration equations121
for the sensor in an elastic membrane chamber measurements are shown in122
Table 1, where the sensor reading, S, is expressed as a linear function of the123
imposed pressure, PIN .124
Table 1: Sensor needle device calibration equations.
Equation Needle
S = aPIN + b 30-g 33-g
a 4.16 4.18
b -13 -17
Ex vivo Rabbit eyes: The same test was conducted in rabbit eyes,125
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with the sensor acquisition rate at 50ms (20Hz) for both the needles, 30-g ×126
1/2 in and 33-g × 1/2 in. The calibration equations from the elastic membrane127
chamber (Table 1) were used to infer the IOP from the sensor needle device128
such that: PM =
S+13
4.16




PM is the measured pressure and S is the sensor reading. The sensor device130
measurements were compared against those obtained by the Tonopen. The131
results in Figure 4 demonstrate the accuracy of the device with a strong linear132
correlation between the imposed (PIN , x-axis) and measured (PM , y-axis)133
pressure for both the 30-g and 33-g needles. The coefficient of determination134
(R2) was excellent for both needle sizes (R2 = 1.0 and 0.99 for the 30-135
and 33-g needles, respectively), and the tonopen in both trials (R2 = 0.98136
and 0.99). The data was confirmed to be normal via the Shapiro-Wilk test137
with significance p < 0.05 and n = 10. Pooled variances for the readings138
were used to determine the average standard deviation of each measurement139
device. The average standard deviation of the 30- and 33-g needles (1.32 and140
2.7 mm Hg, respectively) were much smaller than that of the Tonopen in141
either trial (6.12 and 9.02 mm Hg, respectively).142
Figure 4: Anterior chamber pressure measurements using the sensor needle
device and tonometry for a) 30-g Needle, b) 33-g Needle.
The relative error was evaluated as PIN−PM
PE
, where PIN is the pressure im-143
posed by the microfluidics control system, and PM is the pressure measured144
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by either the sensor needle device or the Tonopen. The Tonopen underes-145
timates the delivered pressure, particularly at higher pressures, where the146
relative error for readings obtained by the Tonopen compared to the sensor147
needle are significantly larger as shown in Figure 5. In contrast, the sensor148
needle device exhibits higher accuracy at higher pressures.149
Figure 5: Error in the anterior chamber pressure measurements using the sensor
needle device and tonometry for a) 30-g Needle, b) 33-g Needle.
The tests were repeated in the vitreous chamber of vitrectomized rabbit150
eyes. Results in Figure 6 show the coefficient of determination was excellent151
for both needle sizes (R2 = 1 and 0.998 for 30- and 33-g needles, respectively).152
By comparison, the Tonopen readings exhibit a slightly lower coefficient of153
determination (R2 = 0.97 and 0.98, for tests with the 30- and 33-g needles,154
respectively).155
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Figure 6: Vitreous chamber pressure measurements obtained using the sensor
needle device and tonometry for a) 30-g Needle, b) 33-g Needle.
The Tonopen also underestimates the pressure readings by over 20% on156
average as shown in Figure 7. The slightly higher error for the 33-g in157
comparison to the 30-g needle can be attributed to the loss in pressure trans-158
mission across the smaller needles’ lumen when transmitting pressure from159
the vitreous chamber to the pressure sensor.160
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Figure 7: Error in the vitreous chamber pressure measurements using the sen-
sor needle device and tonometry for a) 30-g Needle, b) 33-g Needle. As the
imposed pressure, PIN increases, the error for the readings obtained by tonom-
etry fluctuate or get larger while the sensor needle device stabilizes.
4. Discussion161
Advances in microfabrication have allowed the construction of increas-162
ingly sophisticated devices well suited to the small dimensions of the eye.163
Using the technology described above, a high-resolution pressure sensor was164
integrated with a 30- and 33-gauge needle to accurately and reliably measure165
IOP in the anterior and vitreous chambers. Notably, the device provides a166
direct measure of IOP that is not affected by corneal properties. The device167
accurately measured IOP in the anterior chamber over a clinically significant168
range of 10 – 100 mm Hg (Figure 4), opening avenue for its translation to169
use in patients with altered corneal biomechanics. In contrast, the Tonopen170
underestimated the IOP, particularly at higher pressures. This finding is171
consistent with prior studies showing the Tonopen underestimates IOP in172
rabbits.12173
IOP measurements in rabbits can be corrected to account for thinner174
corneas leading to the underestimation of their IOP.13 Similar correction175
factors exist for humans, but their use may not lead to increased accuracy in176
IOP estimation due to many other factors that may induce artifacts.14 More177
complex models that attempt to address additional factors such as the mod-178
ulus of elasticity are still prone to error.15,16 A history of refractive surgery179
may lead to further inaccuracies in the measurement of IOP due to thin-180
ning of the cornea, changes in the corneal curvature, and alterations in the181
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corneal biomechanical properties.17–19 Corneal scars may influence IOP in182
even more unpredictable ways due to their varying sizes, depths, and effects183
on the cornea’s biomechanical properties.20 All of these potential sources of184
error are frequently encountered in the clinical setting, yet there are limited185
means to address them. Our device allows for an accurate measurement of186
IOP in any of these cases. The patient may not need this measurement187
repeated at every visit if the results are reassuring or can be correlated to188
GAT or another non-invasive measurement technique. However, the oppor-189
tunity for direct IOP measurement would be a useful addition to a clinician’s190
armamentarium.191
The device also accurately measured IOP in the vitreous chamber af-192
ter vitrectomy (Figure 6). We were unable to measure IOP in the vitreous193
chamber without vitrectomy because vitreous rapidly clogged the measure-194
ment needle, voiding the sensor reading. A similar result was found in prior195
cannulation studies.21 However, despite this limitation, direct measurement196
of IOP in the vitreous chamber following vitrectomy is clinically useful. As197
many as 60% of Kpro patients develop glaucoma, but the disease is difficult198
to manage due to the inability to accurately measure IOP.22 Management199
of chronic vision-threatening complications like glaucoma in Kpro patients200
is becoming increasingly important as early complications such as endoph-201
thalmitis or device extrusion are becoming less common.23,24 Many Kpro202
patients receive vitrectomies at the time of Kpro implantation. These pa-203
tients may benefit enormously from the accurate measurement of IOP in the204
vitreous chamber.205
Telemetric IOP monitors have been implanted into a small cohort of KPro206
patients and offers an alternative method for direct measurement of IOP in207
these patients.25 However, three of twelve devices were explanted over the208
course of a year and there were concerns for potential adverse events associ-209
ated with the devices. Our device may offer a safe alternative in Kpro pa-210
tients. Interestingly, data from the implantable IOP monitors were compared211
to anterior chamber manometry.26 This suggests that it may be possible to212
measure IOP using our device in KPro patients even without vitrectomy.213
However, serial anterior segment imaging has demonstrated progressive an-214
gle closure and shallowing of the anterior chamber in KPro patients, so an-215
terior chamber measurements may still not be viable over the long term.27216
Implantable devices also face issues of measurement drift over the lifetime of217
the device.28,29 Implantable devices can be re-calibrated to correct for drift218
by performing GAT in healthy eyes, but this is not possible in KPro patients.219
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Our device may be useful for re-calibration of implantable devices as their220
safety profiles become more acceptable.221
The use of the term “gold standard” to describe a diagnostic technique222
or therapeutic intervention has been criticized as inaccurate or misleading223
due to the rapidly evolving state of medical care.30,31 Nonetheless, GAT has224
long been referred to as the gold standard for IOP measurement.1 How-225
ever, accurate measurement of IOP by GAT is hampered by the corneal226
and biomechanical artifacts discussed above. Anterior chamber cannulation227
manometry in animal models allows for accurate IOP measurement but was228
previously hampered by the invasiveness of the technique.32,33 Now, micro-229
fabrication techniques allow clinicians to directly measure IOP through the230
use of implantable devices or minimally invasive procedures. Thus, a true231
IOP is measured rather than the surrogate IOP measured by non-invasive232
techniques. We propose that these new methods will become the true gold233
standard for IOP measurement as they become more broadly applicable.234
This study had several limitations. First, the study was performed en-235
tirely in ex vivo models so the potential long-term complication rates of236
direct measurement of IOP in the anterior and vitreous chambers are un-237
known. However, the safety profiles of anterior chamber paracentesis and238
intravitreal injections offer promise for a similarly safe procedure that could239
be performed in an office setting. Second, we performed vitreous chamber240
measurements in only two eyes. The difficulty of fully closing sclerotomies241
following vitrectomy led to unstable eyes and variable IOP measurements at242
higher pressures. Eyes that are allowed to heal and develop fully watertight243
closures following vitrectomy are not expected to face similar inaccuracies.244
Finally, the current device requires a USB connection to a computer to ob-245
tain readings, future iterations adapting advancements in wireless technology246
would enable further miniaturization and portability, paving the way for clin-247
ical translation of the device in humans.248
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